Literature DB >> 21526258

The anticancer drug cisplatin can cross-link the interdomain zinc site on human albumin.

Wenbing Hu1, Qun Luo, Kui Wu, Xianchan Li, Fuyi Wang, Yi Chen, Xiaoyan Ma, Jianping Wang, Jianan Liu, Shaoxiang Xiong, Peter J Sadler.   

Abstract

Cisplatin, cis-[Pt(Cl(2)(NH(3))(2)], can crosslink residues His67 of domain I and His247 of domain II in human albumin, occupying the major binding site for the essential metal zinc on the protein.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21526258     DOI： 10.1039/c1cc11627d

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  14 in total

1.  Development of high throughput screening assays and pilot screen for inhibitors of metalloproteases meprin α and β.

Authors:  Franck Madoux; Claudia Tredup; Timothy P Spicer; Louis Scampavia; Peter S Chase; Peter S Hodder; Gregg B Fields; Christoph Becker-Pauly; Dmitriy Minond
Journal:  Biopolymers       Date:  2014-09       Impact factor: 2.505

2.  Hemorrhagic shock and surgical stress alter distribution of labile zinc within high- and low-molecular-weight plasma fractions.

Authors:  Edward Kelly; Jeff Mathew; Jonathan E Kohler; Amy L Blass; And David I Soybel
Journal:  Shock       Date:  2012-08       Impact factor: 3.454

3.  Direct determination of the binding sites of cisplatin on insulin-like growth factor-1 by top-down mass spectrometry.

Authors:  Ningbo Zhang; Huan Liu; Meng Cui; Yonggang Du; Zhiqiang Liu; Shuying Liu
Journal:  J Biol Inorg Chem       Date:  2014-10-25       Impact factor: 3.358

Review 4.  The role of zinc and its compounds in leukemia.

Authors:  Alexey P Orlov; Marina A Orlova; Tatiana P Trofimova; Stepan N Kalmykov; Dmitry A Kuznetsov
Journal:  J Biol Inorg Chem       Date:  2018-02-28       Impact factor: 3.358

5.  Mass spectrometry evidence for cisplatin as a protein cross-linking reagent.

Authors:  Huilin Li; Yao Zhao; Hazel I A Phillips; Yulin Qi; Tzu-Yung Lin; Peter J Sadler; Peter B O'Connor
Journal:  Anal Chem       Date:  2011-06-02       Impact factor: 6.986

6.  Copper(ii) complexes based on quinoline-derived Schiff-base ligands: synthesis, characterization, HSA/DNA binding ability, and anticancer activity.

Authors:  Kun Hu; Chensi Liu; Jingui Li; Fupei Liang
Journal:  Medchemcomm       Date:  2018-09-06       Impact factor: 3.597

Review 7.  Metallodrugs are unique: opportunities and challenges of discovery and development.

Authors:  Elizabeth J Anthony; Elizabeth M Bolitho; Hannah E Bridgewater; Oliver W L Carter; Jane M Donnelly; Cinzia Imberti; Edward C Lant; Frederik Lermyte; Russell J Needham; Marta Palau; Peter J Sadler; Huayun Shi; Fang-Xin Wang; Wen-Ying Zhang; Zijin Zhang
Journal:  Chem Sci       Date:  2020-11-12       Impact factor: 9.825

8.  Isolation and characterization of serum albumin from Camelus dromedarius.

Authors:  Ajamaluddin Malik; Abdulrahman Al-Senaidy; Ewa Skrzypczak-Jankun; Jerzy Jankun
Journal:  Exp Ther Med       Date:  2013-06-06       Impact factor: 2.447

9.  Native electrospray mass spectrometry approaches to probe the interaction between zinc and an anti-angiogenic peptide from histidine-rich glycoprotein.

Authors:  Esther M Martin; Frances D L Kondrat; Alan J Stewart; James H Scrivens; Peter J Sadler; Claudia A Blindauer
Journal:  Sci Rep       Date:  2018-06-05       Impact factor: 4.379

Review 10.  Ischemia-modified albumin: Crosstalk between fatty acid and cobalt binding.

Authors:  James P C Coverdale; Kondwani G H Katundu; Amélie I S Sobczak; Swati Arya; Claudia A Blindauer; Alan J Stewart
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2018-07-20       Impact factor: 4.006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.